Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Cancer Medicine
|
February 28, 2014
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
Yingmiao Liu, Mark D Starr, John C Brady, et al.
Journal of Geriatric Oncology
|
February 25, 2019
Clinical prognostic model for older patients with advanced non-small cell lung cancer
Apar Kishor Ganti, Xiaofei Wang, Thomas E Stinchcombe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2015
Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing
Jingquan Jia, Andrew E Dellinger, Eric S Weiss, et al.
Clinical and Translational Science
|
February 19, 2025
Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
Jie Chen, Junrui Di, Nadia Daizadeh, et al.
The Annals of Thoracic Surgery
|
December 16, 2014
VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance)
Chukwumere E Nwogu, Jonathan D'Cunha, Herbert Pang, et al.
Anticancer Research
|
January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer
Nan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
Cancer Chemotherapy and Pharmacology
|
December 21, 2014
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
Hope E Uronis, Jingquan Jia, Johanna C Bendell, et al.
Molecular Cancer Therapeutics
|
February 20, 2015
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus
Yingmiao Liu, Mark D Starr, John C Brady, et al.
Frontiers in Oncology
|
November 17, 2022
A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
Aya El Helali, Jun Tao, Charlene H L Wong, et al.
JAMA
|
April 4, 2013
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial
Ellen M Lavoie Smith, Herbert Pang, Constance Cirrincione, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Cancer Medicine
|
February 28, 2014
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
Yingmiao Liu, Mark D Starr, John C Brady, et al.
Journal of Geriatric Oncology
|
February 25, 2019
Clinical prognostic model for older patients with advanced non-small cell lung cancer
Apar Kishor Ganti, Xiaofei Wang, Thomas E Stinchcombe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2015
Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing
Jingquan Jia, Andrew E Dellinger, Eric S Weiss, et al.
Clinical and Translational Science
|
February 19, 2025
Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
Jie Chen, Junrui Di, Nadia Daizadeh, et al.
The Annals of Thoracic Surgery
|
December 16, 2014
VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance)
Chukwumere E Nwogu, Jonathan D'Cunha, Herbert Pang, et al.
Anticancer Research
|
January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer
Nan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
Cancer Chemotherapy and Pharmacology
|
December 21, 2014
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
Hope E Uronis, Jingquan Jia, Johanna C Bendell, et al.
Molecular Cancer Therapeutics
|
February 20, 2015
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus
Yingmiao Liu, Mark D Starr, John C Brady, et al.
Frontiers in Oncology
|
November 17, 2022
A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
Aya El Helali, Jun Tao, Charlene H L Wong, et al.
JAMA
|
April 4, 2013
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial
Ellen M Lavoie Smith, Herbert Pang, Constance Cirrincione, et al.
Page
of 11